The extracellular matrix glycoprotein elastin microfibril interface located protein 2: A dual role in the tumor microenvironment

Maurizio Mongiat, Stefano Marastoni, Giovanni Ligresti, Erica Lorenzon, Monica Schiappacassi, Roberto Perris, Sergio Frustaci, Alfonso Colombatti

Research output: Contribution to journalArticle

Abstract

We have recently reported that elastin microfibril interface located protein 2 (EMILIN2), an extracellular matrix (ECM) glycoprotein, triggers cell death through a direct binding to death receptors. EMILIN2 thus influences cell viability through a mechanism that is unique for an ECM molecule. In the present work, we report an additional function for this molecule. First, we identify the region responsible for the proapoptotic effects, a 90-amino acid residue-long coiled-coil fragment toward the N-terminus of the molecule. The fragment recapitulates EMILIN2 proapoptotic mechanisms. In addition, using either the full molecule or the active fragment, for the first time, we demonstrate a significant antitumoral effect in vivo, likely due to a decrease in tumor cell viability. Unexpectedly, tumors treated with EMILIN2 or the deletion mutant display a significant increase of tumor angiogenesis. In view of this novel finding, the cotreatment of the growing tumors with an antiangiogenic drug led, in most cases, to a complete regression of tumor growth. These results grant further support to recent findings that pinpoint the microenvironment as an important regulator of cell fate under both physiological and pathological conditions and disclose the possibility of using EMILIN2 fragments as potent antineoplastic tools for cancer treatment.

Original languageEnglish
Pages (from-to)294-304
Number of pages11
JournalNeoplasia (United States)
Volume12
Issue number4
DOIs
Publication statusPublished - Apr 2010

Fingerprint

Tumor Microenvironment
Extracellular Matrix
Glycoproteins
Neoplasms
Cell Survival
Death Domain Receptors
Antineoplastic Agents
elastin microfibril interface located protein
Cell Death
Amino Acids
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research

Cite this

The extracellular matrix glycoprotein elastin microfibril interface located protein 2 : A dual role in the tumor microenvironment. / Mongiat, Maurizio; Marastoni, Stefano; Ligresti, Giovanni; Lorenzon, Erica; Schiappacassi, Monica; Perris, Roberto; Frustaci, Sergio; Colombatti, Alfonso.

In: Neoplasia (United States), Vol. 12, No. 4, 04.2010, p. 294-304.

Research output: Contribution to journalArticle

Mongiat, M, Marastoni, S, Ligresti, G, Lorenzon, E, Schiappacassi, M, Perris, R, Frustaci, S & Colombatti, A 2010, 'The extracellular matrix glycoprotein elastin microfibril interface located protein 2: A dual role in the tumor microenvironment', Neoplasia (United States), vol. 12, no. 4, pp. 294-304. https://doi.org/10.1593/neo.91930
Mongiat, Maurizio ; Marastoni, Stefano ; Ligresti, Giovanni ; Lorenzon, Erica ; Schiappacassi, Monica ; Perris, Roberto ; Frustaci, Sergio ; Colombatti, Alfonso. / The extracellular matrix glycoprotein elastin microfibril interface located protein 2 : A dual role in the tumor microenvironment. In: Neoplasia (United States). 2010 ; Vol. 12, No. 4. pp. 294-304.
@article{028bc4aa62c84da89b13e40b0766ae98,
title = "The extracellular matrix glycoprotein elastin microfibril interface located protein 2: A dual role in the tumor microenvironment",
abstract = "We have recently reported that elastin microfibril interface located protein 2 (EMILIN2), an extracellular matrix (ECM) glycoprotein, triggers cell death through a direct binding to death receptors. EMILIN2 thus influences cell viability through a mechanism that is unique for an ECM molecule. In the present work, we report an additional function for this molecule. First, we identify the region responsible for the proapoptotic effects, a 90-amino acid residue-long coiled-coil fragment toward the N-terminus of the molecule. The fragment recapitulates EMILIN2 proapoptotic mechanisms. In addition, using either the full molecule or the active fragment, for the first time, we demonstrate a significant antitumoral effect in vivo, likely due to a decrease in tumor cell viability. Unexpectedly, tumors treated with EMILIN2 or the deletion mutant display a significant increase of tumor angiogenesis. In view of this novel finding, the cotreatment of the growing tumors with an antiangiogenic drug led, in most cases, to a complete regression of tumor growth. These results grant further support to recent findings that pinpoint the microenvironment as an important regulator of cell fate under both physiological and pathological conditions and disclose the possibility of using EMILIN2 fragments as potent antineoplastic tools for cancer treatment.",
author = "Maurizio Mongiat and Stefano Marastoni and Giovanni Ligresti and Erica Lorenzon and Monica Schiappacassi and Roberto Perris and Sergio Frustaci and Alfonso Colombatti",
year = "2010",
month = "4",
doi = "10.1593/neo.91930",
language = "English",
volume = "12",
pages = "294--304",
journal = "Neoplasia",
issn = "1522-8002",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - The extracellular matrix glycoprotein elastin microfibril interface located protein 2

T2 - A dual role in the tumor microenvironment

AU - Mongiat, Maurizio

AU - Marastoni, Stefano

AU - Ligresti, Giovanni

AU - Lorenzon, Erica

AU - Schiappacassi, Monica

AU - Perris, Roberto

AU - Frustaci, Sergio

AU - Colombatti, Alfonso

PY - 2010/4

Y1 - 2010/4

N2 - We have recently reported that elastin microfibril interface located protein 2 (EMILIN2), an extracellular matrix (ECM) glycoprotein, triggers cell death through a direct binding to death receptors. EMILIN2 thus influences cell viability through a mechanism that is unique for an ECM molecule. In the present work, we report an additional function for this molecule. First, we identify the region responsible for the proapoptotic effects, a 90-amino acid residue-long coiled-coil fragment toward the N-terminus of the molecule. The fragment recapitulates EMILIN2 proapoptotic mechanisms. In addition, using either the full molecule or the active fragment, for the first time, we demonstrate a significant antitumoral effect in vivo, likely due to a decrease in tumor cell viability. Unexpectedly, tumors treated with EMILIN2 or the deletion mutant display a significant increase of tumor angiogenesis. In view of this novel finding, the cotreatment of the growing tumors with an antiangiogenic drug led, in most cases, to a complete regression of tumor growth. These results grant further support to recent findings that pinpoint the microenvironment as an important regulator of cell fate under both physiological and pathological conditions and disclose the possibility of using EMILIN2 fragments as potent antineoplastic tools for cancer treatment.

AB - We have recently reported that elastin microfibril interface located protein 2 (EMILIN2), an extracellular matrix (ECM) glycoprotein, triggers cell death through a direct binding to death receptors. EMILIN2 thus influences cell viability through a mechanism that is unique for an ECM molecule. In the present work, we report an additional function for this molecule. First, we identify the region responsible for the proapoptotic effects, a 90-amino acid residue-long coiled-coil fragment toward the N-terminus of the molecule. The fragment recapitulates EMILIN2 proapoptotic mechanisms. In addition, using either the full molecule or the active fragment, for the first time, we demonstrate a significant antitumoral effect in vivo, likely due to a decrease in tumor cell viability. Unexpectedly, tumors treated with EMILIN2 or the deletion mutant display a significant increase of tumor angiogenesis. In view of this novel finding, the cotreatment of the growing tumors with an antiangiogenic drug led, in most cases, to a complete regression of tumor growth. These results grant further support to recent findings that pinpoint the microenvironment as an important regulator of cell fate under both physiological and pathological conditions and disclose the possibility of using EMILIN2 fragments as potent antineoplastic tools for cancer treatment.

UR - http://www.scopus.com/inward/record.url?scp=77951699330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951699330&partnerID=8YFLogxK

U2 - 10.1593/neo.91930

DO - 10.1593/neo.91930

M3 - Article

C2 - 20360940

AN - SCOPUS:77951699330

VL - 12

SP - 294

EP - 304

JO - Neoplasia

JF - Neoplasia

SN - 1522-8002

IS - 4

ER -